These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 23327323)

  • 21. Development of a Babesia bovis live attenuated vaccine.
    Alonso M; Blandino T; Mendoza E; Savon L; Camacho M
    Arch Med Res; 1994; 25(2):273-7. PubMed ID: 7919825
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Exoantigens of an attenuated strain of Babesia bovis used as a vaccine against bovine babesiosis.
    Patarroyo JH; Prates AA; Tavares CA; Mafra CL; Vargas MI
    Vet Parasitol; 1995 Oct; 59(3-4):189-99. PubMed ID: 8533277
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Investigations of breakdowns in protection provided by living Babesia bovis vaccine.
    Bock RE; de Vos AJ; Kingston TG; Shiels IA; Dalgliesh RJ
    Vet Parasitol; 1992 Jun; 43(1-2):45-56. PubMed ID: 1496802
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Epizootiology of Babesia bovis and Babesia bigemina in free-ranging white-tailed deer in northeastern Mexico.
    Cantu-C A; Ortega-S JA; García-Vázquez Z; Mosqueda J; Henke SE; George JE
    J Parasitol; 2009 Jun; 95(3):536-42. PubMed ID: 19642800
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Artemisone inhibits in vitro and in vivo propagation of Babesia bovis and B. bigemina parasites.
    Mazuz ML; Golenser J; Fish L; Haynes RK; Wollkomirsky R; Leibovich B; Shkap V
    Exp Parasitol; 2013 Dec; 135(4):690-4. PubMed ID: 24184077
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Use of a duplex PCR/DNA probe assay to monitor Babesia bovis and Babesia bigemina in cattle during a vaccination trial.
    Figueroa JV; Alvarez JA; Rojas EE; Ramos JA; Mosqueda JJ; Cantó GJ; Vega CA; Buening GM
    Rev Latinoam Microbiol; 1998; 40(1-2):39-44. PubMed ID: 10932733
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Application of PCR assays to determine the genotype of Babesia bovis parasites isolated from cattle with clinical babesiosis soon after vaccination against tick fever.
    Bock RE; Lew AE; Minchin CM; Jeston PJ; Jorgensen WK
    Aust Vet J; 2000 Mar; 78(3):179-81. PubMed ID: 10860157
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy of South African Babesia bovis vaccine against field isolates.
    Troskie PC; Latif AA; Mans BJ; Combrink MP
    Ticks Tick Borne Dis; 2017 Jun; 8(4):671-674. PubMed ID: 28499721
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Assessment of Babesia bovis 6cys A and 6cys B as components of transmission blocking vaccines for babesiosis.
    Alzan HF; Bastos RG; Ueti MW; Laughery JM; Rathinasamy VA; Cooke BM; Suarez CE
    Parasit Vectors; 2021 Apr; 14(1):210. PubMed ID: 33879245
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serological evidence of exposure to tick fever organisms in young cattle on Queensland dairy farms.
    Sserugga JN; Jonsson NN; Bock RE; More SJ
    Aust Vet J; 2003 Mar; 81(3):147-52. PubMed ID: 15080428
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Transgenic Babesia bovis lacking 6-Cys sexual-stage genes as the foundation for non-transmissible live vaccines against bovine babesiosis.
    Alzan HF; Cooke BM; Suarez CE
    Ticks Tick Borne Dis; 2019 Apr; 10(3):722-728. PubMed ID: 30711475
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Use of long-acting oxytetracycline in the immunisation of cattle against Babesia bovis and B bigemina.
    Pipano E; Markovics A; Kriegel Y; Frank M; Fish L
    Res Vet Sci; 1987 Jul; 43(1):64-6. PubMed ID: 3628985
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Field evaluation of an exoantigen-containing Babesia vaccine in Venezuela.
    Montenegro-James S; Toro M; Leon E; Guillen AT
    Mem Inst Oswaldo Cruz; 1992; 87 Suppl 3():283-8. PubMed ID: 1343704
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Seroprevalence of babesiosis in cattle in Sivas].
    Kalkan K; Ozçelık S; Malatyali E
    Turkiye Parazitol Derg; 2010; 34(1):11-6. PubMed ID: 20340080
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Overcoming constraints to meeting increased demand for Babesia bigemina vaccine in Australia.
    Standfast NF; Bock RE; Wiecek MM; deVos AJ; Jorgensen WK; Kingston TG
    Vet Parasitol; 2003 Jul; 115(3):213-22. PubMed ID: 12935736
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Babesia bovis: analysis of and preliminary vaccination studies with a defined infected erythrocyte membrane binding antigen.
    Goodger BV; Waltisbuhl DJ; Wright IG; White M
    Int J Parasitol; 1992 Jul; 22(4):533-5. PubMed ID: 1644530
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Studies on failure of T strain live Babesia bovis vaccine.
    Bock RE; de Vos AJ; Lew A; Kingston TG; Fraser IR
    Aust Vet J; 1995 Aug; 72(8):296-300. PubMed ID: 8579560
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of common antigens in Babesia bovis, B. bigemina, and B. divergens.
    Figueroa JV; Precigout E; Carcy B; Gorenflot A
    Ann N Y Acad Sci; 2006 Oct; 1081():382-96. PubMed ID: 17135542
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Advances in the development of molecular tools for the control of bovine babesiosis in Mexico.
    Mosqueda J; Figueroa JV; Alvarez A; Bautista R; Falcon A; Ramos A; Canto G; Vega CA
    Parassitologia; 2007 May; 49 Suppl 1():19-22. PubMed ID: 17691602
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Vaccination against bovine babesiosis.
    De Vos AJ; Bock RE
    Ann N Y Acad Sci; 2000; 916():540-5. PubMed ID: 11193669
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.